In this context, GLP-1RAs have emerged as promising candidates for disease modification, owing to their pleiotropic neuroprotective effects demonstrated in preclinical and clinical studies [268, 286]
The European Medicines Agency Investigation The European Medicines Agency conducted its own review of safety data for Ozempic and other GLP-1 drugs
Tranexamic acid, an anti-fibrinolytic medication, is effective in reducing menstrual blood loss but does not influence fibroid growth
Patients should maintain consistent hydration and report dark urine, dizziness, or reduced urination to their healthcare team immediately
Call (770) 771-6591 to schedule a consultation with our physicians.
You should always consult your doctor before starting, stopping, or changing your medication plan